Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Risk Factors for Community-Associated Clostridium difficile Infection in Adults: A Case-Control Study.

Guh AY, Adkins SH, Li Q, Bulens SN, Farley MM, Smith Z, Holzbauer SM, Whitten T, Phipps EC, Hancock EB, Dumyati G, Concannon C, Kainer MA, Rue B, Lyons C, Olson DM, Wilson L, Perlmutter R, Winston LG, Parker E, Bamberg W, Beldavs ZG, Ocampo V, Karlsson M, Gerding DN, McDonald LC.

Open Forum Infect Dis. 2017 Oct 26;4(4):ofx171. doi: 10.1093/ofid/ofx171. eCollection 2017 Fall.

2.

Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012-2015.

Bulens SN, Yi SH, Walters MS, Jacob JT, Bower C, Reno J, Wilson L, Vaeth E, Bamberg W, Janelle SJ, Lynfield R, Vagnone PS, Shaw K, Kainer M, Muleta D, Mounsey J, Dumyati G, Concannon C, Beldavs Z, Cassidy PM, Phipps EC, Kenslow N, Hancock EB, Kallen AJ.

Emerg Infect Dis. 2018 Apr;24(4):727-734. doi: 10.3201/eid2404.171461.

3.

Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013.

Guh AY, Bulens SN, Mu Y, Jacob JT, Reno J, Scott J, Wilson LE, Vaeth E, Lynfield R, Shaw KM, Vagnone PM, Bamberg WM, Janelle SJ, Dumyati G, Concannon C, Beldavs Z, Cunningham M, Cassidy PM, Phipps EC, Kenslow N, Travis T, Lonsway D, Rasheed JK, Limbago BM, Kallen AJ.

JAMA. 2015 Oct 13;314(14):1479-87. doi: 10.1001/jama.2015.12480.

PMID:
26436831
4.

Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae.

Chea N, Bulens SN, Kongphet-Tran T, Lynfield R, Shaw KM, Vagnone PS, Kainer MA, Muleta DB, Wilson L, Vaeth E, Dumyati G, Concannon C, Phipps EC, Culbreath K, Janelle SJ, Bamberg WM, Guh AY, Limbago B, Kallen AJ.

Emerg Infect Dis. 2015 Sep;21(9):1611-6. doi: 10.3201/eid2109.150198.

5.

Trends in invasive methicillin-resistant Staphylococcus aureus infections.

Iwamoto M, Mu Y, Lynfield R, Bulens SN, Nadle J, Aragon D, Petit S, Ray SM, Harrison LH, Dumyati G, Townes JM, Schaffner W, Gorwitz RJ, Lessa FC.

Pediatrics. 2013 Oct;132(4):e817-24. doi: 10.1542/peds.2013-1112. Epub 2013 Sep 23. Review.

6.

Community-onset invasive methicillin-resistant Staphylococcus aureus infections following hospital discharge.

Duffy J, Dumyati G, Bulens S, Namburi S, Gellert A, Fridkin SK, Lessa FC.

Am J Infect Control. 2013 Sep;41(9):782-6. doi: 10.1016/j.ajic.2012.10.020. Epub 2013 Feb 5.

PMID:
23394888
7.

Impact of USA300 methicillin-resistant Staphylococcus aureus on clinical outcomes of patients with pneumonia or central line-associated bloodstream infections.

Lessa FC, Mu Y, Ray SM, Dumyati G, Bulens S, Gorwitz RJ, Fosheim G, DeVries AS, Schaffner W, Nadle J, Gershman K, Fridkin SK; Active Bacterial Core surveillance (ABCs); MRSA Investigators of the Emerging Infections Program.

Clin Infect Dis. 2012 Jul;55(2):232-41. doi: 10.1093/cid/cis408. Epub 2012 Apr 20.

PMID:
22523264
8.

The etiology of severe acute gastroenteritis among adults visiting emergency departments in the United States.

Bresee JS, Marcus R, Venezia RA, Keene WE, Morse D, Thanassi M, Brunett P, Bulens S, Beard RS, Dauphin LA, Slutsker L, Bopp C, Eberhard M, Hall A, Vinje J, Monroe SS, Glass RI; US Acute Gastroenteritis Etiology Study Team.

J Infect Dis. 2012 May 1;205(9):1374-81. doi: 10.1093/infdis/jis206. Epub 2012 Mar 27.

PMID:
22454468
9.

Enhanced surveillance of norovirus outbreaks of gastroenteritis in Georgia.

Widdowson MA, Bulens SN, Beard RS, Lane KM, Monroe SS, Lance S, Bresee JS, Glass RI.

Public Health Rep. 2011 Mar-Apr;126(2):251-8.

10.

Clinical and laboratory characteristics of invasive infections due to methicillin-resistant Staphylococcus aureus isolates demonstrating a vancomycin MIC of 2 micrograms per milliliter: lack of effect of heteroresistant vancomycin-intermediate S. aureus phenotype.

Satola SW, Lessa FC, Ray SM, Bulens SN, Lynfield R, Schaffner W, Dumyati G, Nadle J, Patel JB; Active Bacterial Core surveillance (ABCs) MRSA Investigators.

J Clin Microbiol. 2011 Apr;49(4):1583-7. doi: 10.1128/JCM.01719-10. Epub 2011 Feb 16.

11.

Health care-associated invasive MRSA infections, 2005-2008.

Kallen AJ, Mu Y, Bulens S, Reingold A, Petit S, Gershman K, Ray SM, Harrison LH, Lynfield R, Dumyati G, Townes JM, Schaffner W, Patel PR, Fridkin SK; Active Bacterial Core surveillance (ABCs) MRSA Investigators of the Emerging Infections Program.

JAMA. 2010 Aug 11;304(6):641-8. doi: 10.1001/jama.2010.1115.

PMID:
20699455
12.

Emergence of resistance among USA300 methicillin-resistant Staphylococcus aureus isolates causing invasive disease in the United States.

McDougal LK, Fosheim GE, Nicholson A, Bulens SN, Limbago BM, Shearer JE, Summers AO, Patel JB.

Antimicrob Agents Chemother. 2010 Sep;54(9):3804-11. doi: 10.1128/AAC.00351-10. Epub 2010 Jun 28.

13.

Typhoid fever in the United States, 1999-2006.

Lynch MF, Blanton EM, Bulens S, Polyak C, Vojdani J, Stevenson J, Medalla F, Barzilay E, Joyce K, Barrett T, Mintz ED.

JAMA. 2009 Aug 26;302(8):859-65. doi: 10.1001/jama.2009.1229.

PMID:
19706859
14.

Evaluating the potential public health impact of a Staphylococcus aureus vaccine through use of population-based surveillance for invasive methicillin-resistant S. aureus disease in the United States.

Lucero CA, Hageman J, Zell ER, Bulens S, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Schaffner W, Fridkin SK; Active Bacterial Core surveillance MRSA Investigators.

Vaccine. 2009 Aug 13;27(37):5061-8. doi: 10.1016/j.vaccine.2009.06.055. Epub 2009 Jul 2.

PMID:
19576943
15.

Evaluation of universal antenatal screening for group B streptococcus.

Van Dyke MK, Phares CR, Lynfield R, Thomas AR, Arnold KE, Craig AS, Mohle-Boetani J, Gershman K, Schaffner W, Petit S, Zansky SM, Morin CA, Spina NL, Wymore K, Harrison LH, Shutt KA, Bareta J, Bulens SN, Zell ER, Schuchat A, Schrag SJ.

N Engl J Med. 2009 Jun 18;360(25):2626-36. doi: 10.1056/NEJMoa0806820.

16.

Surveillance for severe community-associated methicillin-resistant Staphylococcus aureus infection.

Wiersma P, Tobin D'Angelo M, Daley WR, Tuttle J, Arnold KE, Ray SM, Ladson JL, Bulens SN, Drenzek CL.

Epidemiol Infect. 2009 Dec;137(12):1674-8. doi: 10.1017/S0950268809002490. Epub 2009 Apr 15.

PMID:
19366491
17.

Characterization of methicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: a population-based analysis.

Limbago B, Fosheim GE, Schoonover V, Crane CE, Nadle J, Petit S, Heltzel D, Ray SM, Harrison LH, Lynfield R, Dumyati G, Townes JM, Schaffner W, Mu Y, Fridkin SK; Active Bacterial Core surveillance MRSA Investigators.

J Clin Microbiol. 2009 May;47(5):1344-51. doi: 10.1128/JCM.02264-08. Epub 2009 Mar 25.

18.

Trends in perinatal group B streptococcal disease - United States, 2000-2006.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Feb 13;58(5):109-12.

19.

Severe diarrhea caused by cholera toxin-producing vibrio cholerae serogroup O75 infections acquired in the southeastern United States.

Tobin-D'Angelo M, Smith AR, Bulens SN, Thomas S, Hodel M, Izumiya H, Arakawa E, Morita M, Watanabe H, Marin C, Parsons MB, Greene K, Cooper K, Haydel D, Bopp C, Yu P, Mintz E.

Clin Infect Dis. 2008 Oct 15;47(8):1035-40. doi: 10.1086/591973.

PMID:
18781876
20.

Molecular and epidemiologic trends of caliciviruses associated with outbreaks of acute gastroenteritis in the United States, 2000-2004.

Blanton LH, Adams SM, Beard RS, Wei G, Bulens SN, Widdowson MA, Glass RI, Monroe SS.

J Infect Dis. 2006 Feb 1;193(3):413-21. Epub 2005 Dec 21.

PMID:
16388489

Supplemental Content

Loading ...
Support Center